In an Aug. 8 Facebook post, Sen. John F. Curran announced that Illinois diabetics would see the cost of their insulin capped. Legislators took up the cause after other states have moved to cap the cost of insulin.
“The Illinois Senate Republican Caucus unanimously voted for HB 2189 to help cap the cost of insulin for high-risk diabetics,” Curran said. “Helping make vital health care more affordable for all Illinoisans continues to be one of our top priorities.”
John F. Curran was first elected to the Illinois Senate in 2017. A Republican, their legislative experience includes serving on the Appropriations II Committee and Assignments Committee. Curran is a state senator who resides in Downers Grove, according to the Illinois Senate.
In his Facebook post, Sen. Curran shared a link to a WAND TV report on the new bill. According to the report, Gov. Pritzker signed the bill on Friday, Aug. 4, and this isn’t the only time that legislators have capped the price of insulin, although the 2019 cap did not apply universally. According to the news outlet, that cap “covered roughly 15% of people under insurance for Illinois state employees.”
The Access to Affordable Insulin Act, first known as House Bill 2189, then as Public Act 103-0429, was first filed by Rep. Will Guzzardi, and “In provisions concerning cost sharing in prescription insulin drugs, provides that an insurer that provides coverage for prescription insulin drugs under the terms of a health coverage plan the insurer offers shall limit the total amount that an insured is required to pay for a 30-day supply of covered prescription insulin drugs at an amount not to exceed $35 (rather than $100.)” The bill will go into effect on July 1, 2025.
Sen. John F. Curran represents the people of the 41st Senate District and has done so since July 2017. He and his family live in Downers Grove.
